Estimate the patient evidence scope your launch may need across disease areas, target markets, and strategic objectives.
* Required fields





Calculate your minimum patient intelligence threshold — based on your disease areas, target markets, and launch objectives.
It scopes the minimum patient evidence your drug launch needs — how many verified patient conversations, data points, and interview hours your team requires to make confident decisions across your disease areas and markets.
A personalised scope summary with your minimum patient cohort size, estimated data points, and interview hours — then a call with our team to walk through what that intelligence looks like for your specific launch.
Pharma and biotech launch teams across Marketing, Commercial, Medical Affairs, Market Access, and Patient Advocacy — anyone making decisions about patient behavior, treatment journeys, or unmet needs.
mama health is a patient intelligence platform that runs AI-moderated patient interviews at scale across 20+ disease areas and 15+ markets — delivering a live dashboard of structured patient intelligence, refreshed weekly, for life science launch teams.
We recruit and condition-verify patients, then conduct 30–60 minute AI-moderated interviews covering their full journey. Every interview is clinician-reviewed and structured into a consistent schema, with patients enrolling continuously so your data stays fresh.
Surveys capture ticks. HCP panels capture physician recall. mama health captures what patients actually experience — open-ended, unprompted, AI-moderated interviews that surface behavioral nuance and treatment decision logic that structured questionnaires miss.
50,000+ patient interviews across 15+ markets and 20+ disease areas. The calculator uses 150+ verified patients per market as the minimum threshold for journey-level insights.
20+ areas including Lupus, Psoriasis, Atopic Dermatitis, RA, MS, Myasthenia Gravis, IBD, Crohn's, COPD, Type 2 Diabetes, Migraine, Parkinson's, and more. Enter any disease manually — our team will confirm coverage on your call.
Estimated minimum patient intelligence threshold for your selected disease-market scope.